|
Novel |
ADAM32 |
ADAM metallopeptidase domain 32 |
|
|
|
|
Novel |
HTRA4 |
HtrA serine peptidase 4 |
|
|
|
|
Novel |
PLEKHA7 |
pleckstrin homology domain containing A7 |
|
|
|
|
Novel |
SCN8A |
sodium voltage-gated channel alpha subunit 8 |
- Interaction between L1 and Ankyrins
- Phase 0 - rapid depolarisation
|
- Ranolazine
- Phenytoin
- Topiramate
- Valproic acid
- Lamotrigine
- Carbamazepine
- Oxcarbazepine
- Cocaine
- Promethazine
- Chloroprocaine
- Tetrodotoxin
- Brivaracetam
- Tetracaine
- Amylocaine
- Propoxycaine
- Pramocaine
- Pentoxyverine
- Dichlorobenzyl alcohol
- Bioallethrin
- Fish oil
|
|
|
|
DYRK1A |
dual specificity tyrosine phosphorylation regulated kinase 1A |
|
- N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide
- Fostamatinib
|
|
|
|
ITGA3 |
integrin subunit alpha 3 |
- Basigin interactions
- Integrin cell surface interactions
- Integrin cell surface interactions
- Laminin interactions
- MET activates PTK2 signaling
|
|
|
|
|
ITGA6 |
integrin subunit alpha 6 |
- Assembly of collagen fibrils and other multimeric structures
- Basigin interactions
- Integrin cell surface interactions
- Integrin cell surface interactions
- Laminin interactions
- Laminin interactions
- Syndecan interactions
- Type I hemidesmosome assembly
- Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin
- Developmental Lineage of Mammary Gland Luminal Epithelial Cells
- Developmental Lineage of Mammary Gland Alveolar Cells
- Developmental Lineage of Mammary Gland Myoepithelial Cells
- Developmental Lineage of Mammary Stem Cells
|
|
- Epidermolysis bullosa, junctional, including: Epidermolysis bullosa, junctional, Herlitz type (JEB-H); Epidermolysis bullosa, junctional, non-Herlitz type (JEB-nH); Epidermolysis bullosa, junctional, with pyloric atresia (JEB-PA)
|
|
|
ITGAV |
integrin subunit alpha V |
- Cross-presentation of particulate exogenous antigens (phagosomes)
- Elastic fibre formation
- PECAM1 interactions
- Molecules associated with elastic fibres
- Integrin cell surface interactions
- Integrin cell surface interactions
- TGF-beta receptor signaling activates SMADs
- Laminin interactions
- Syndecan interactions
- Syndecan interactions
- ECM proteoglycans
- VEGFA-VEGFR2 Pathway
- Signal transduction by L1
- Neutrophil degranulation
- Mechanical load activates signaling by PIEZO1 and integrins in osteocytes
- Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
|
- Antithymocyte immunoglobulin (rabbit)
- Levothyroxine
- PLN-74809
|
|
|
|
MAD2L2 |
mitotic arrest deficient 2 like 2 |
- Translesion synthesis by REV1
- Translesion synthesis by POLK
- Translesion synthesis by POLI
|
|
|
|
|
PRKCD |
protein kinase C delta |
- Apoptotic cleavage of cellular proteins
- Calmodulin induced events
- Effects of PIP2 hydrolysis
- SHC1 events in ERBB2 signaling
- DAG and IP3 signaling
- Role of phospholipids in phagocytosis
- G alpha (z) signalling events
- HuR (ELAVL1) binds and stabilizes mRNA
- VEGFR2 mediated cell proliferation
- CLEC7A (Dectin-1) signaling
- RHO GTPases Activate NADPH Oxidases
- Neutrophil degranulation
- Interferon gamma signaling
- KEAP1-NFE2L2 pathway
|
- Tamoxifen
- Staurosporine
- Dequalinium
- 13-Acetylphorbol
- Ingenol mebutate
- Benzoyl peroxide
- Fostamatinib
|
|
|
|
SH3D19 |
SH3 domain containing 19 |
- Golgi Associated Vesicle Biogenesis
|
|
|
|
|
SH3GLB1 |
SH3 domain containing GRB2 like, endophilin B1 |
|
|
|
|
|
SNX9 |
sorting nexin 9 |
- Golgi Associated Vesicle Biogenesis
- Clathrin-mediated endocytosis
|
|
|
|
|
TNF |
tumor necrosis factor |
- Transcriptional regulation of white adipocyte differentiation
- TNFR1-induced proapoptotic signaling
- Regulation of TNFR1 signaling
- TNFR1-induced NF-kappa-B signaling pathway
- TNFR1-mediated ceramide production
- TNFR2 non-canonical NF-kB pathway
- Interleukin-10 signaling
- Interleukin-4 and Interleukin-13 signaling
- TNF signaling
- Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells)
|
- Etanercept
- Adalimumab
- Infliximab
- Chloroquine
- Epinephrine
- Pseudoephedrine
- Clenbuterol
- Pranlukast
- Amrinone
- Trichostatin A
- Afelimomab
- YSIL6
- SD118
- PN0621
- OMS-103HP
- Talmapimod
- VX-702
- Atiprimod
- CRx-139
- CYT007-TNFQb
- Andrographolide
- Ethyl pyruvate
- AME-527
- PR-104
- Plinabulin
- Dexanabinol
- Onercept
- Golimumab
- Certolizumab pegol
- Pomalidomide
- Polaprezinc
- Foreskin fibroblast (neonatal)
- Foreskin keratinocyte (neonatal)
- Bryostatin 1
- Binimetinib
- Dilmapimod
- Glycyrrhizic acid
|
- Graft-versus-host disease
- Systemic lupus erythematosus
- Allograft rejection
- Asthma
|